Ot Pediatric denied as experimental or investigational by Anthem (BCBS)?

Anthem (BCBS)'s specific coverage criteria for ot pediatric are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Anthem BCBS Denies Pediatric OT as Experimental or Investigational

An "experimental or investigational" denial for pediatric occupational therapy typically targets a specific OT modality or approach rather than OT as a whole. Common targets include sensory integration therapy (SIT), therapeutic listening programs, Interactive Metronome, vision therapy components, and certain neurodevelopmental intervention protocols. Anthem BCBS maintains clinical coverage policies that classify specific therapy modalities as experimental when Anthem's medical policy team has determined that the evidence base does not yet meet its threshold for coverage.

## Why This Denial Is Appealable

Experimental/investigational denials are among the most heavily contested in pediatric therapy. The central appealable issue is whether Anthem's evidence review is current, complete, and applicable to your child's specific diagnosis. The American Occupational Therapy Association (AOTA) and relevant specialty organizations publish evidence-based practice guidelines that may support the modality at issue. If the treating OT can cite a substantial body of peer-reviewed literature supporting the specific approach for the child's documented diagnosis, the experimental classification may not hold.

Under federal external review rules, IROs must apply "generally accepted standards of medical practice" — not an individual insurer's evidence threshold — when reviewing experimental/investigational denials for conditions with serious consequences, including pediatric developmental disorders.

## Federal Appeal Framework

• Internal appeal (ERISA §503 / ACA §2719): File a written appeal with clinical and scientific literature supporting the specific modality for the child's diagnosis. Request that the internal reviewer be a qualified occupational therapist or pediatric rehabilitation specialist.
• External review: Escalate to independent external review if the internal appeal fails. IROs apply broadly accepted clinical standards, which may be more favorable than Anthem's own policy threshold. The external-review window is typically around four months from denial.
• Expedited review: Available if developmental delay from denial of treatment poses an urgent clinical risk.

## Timeline

Request Anthem's specific clinical coverage policy that classifies the modality as experimental. Review its evidence criteria and the date of its most recent update — an outdated policy review is itself a basis for appeal.

## Documentation to Gather

• Anthem's experimental/investigational policy: The specific coverage policy and its effective date. A policy not updated in several years may be based on an outdated evidence review.
• Diagnosis and evaluation: Comprehensive OT evaluation documenting the child's diagnosis, functional deficits, and the clinical rationale for the specific modality.
• Evidence support: A letter from the treating OT citing the relevant professional guideline organization (e.g., AOTA) and the general body of published evidence supporting the modality for the child's specific diagnosis — without citing specific statistics or trial names.
• Clinical response documentation: If the modality has already been initiated, any clinical progress notes documenting the child's functional response.
• Prescribing/referring physician support: A letter from the child's physician endorsing the OT's treatment approach as consistent with accepted pediatric practice for the diagnosed condition.

## Criteria-Mapping Structure

In your appeal, directly address Anthem's stated basis for the experimental classification: quote the policy language, then present the clinical and scientific context that challenges it. For each element of Anthem's exclusion criteria, provide the corresponding clinical or evidentiary rebuttal, supported by attached documentation.